Compare DexCom, Inc. (DXCM) vs Super Micro Computer Inc (SMCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Super Micro Computer Inc — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while Super Micro Computer Inc trades at $41.7 (market cap $28.10B). The key difference: DexCom, Inc. and Super Micro Computer Inc are close in size by market cap, and DexCom, Inc. is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Super Micro Computer Inc for 19 Days on average.
| DXCM | SMCI | |
|---|---|---|
Market Cap | $31.86B | $28.10B |
Volume | 3,607,070 | 38,581,805 |
Sector | Health | Technology |
52-Week High | $92.34 | $57.98 |
52-Week Low | $54.84 | $20.53 |
Typical Hold Time | 62 Days | 19 Days |
Enterprise Value | $31.32B | $33.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.
Super Micro Computer (SMCI) trades at $41.34, down 8.03% in the last session, but maintains strong fundamental performance with consistent earnings beats and robust revenue growth projections. The stock shows bullish technical signals with support at $40 and resistance at $44, while valuation metrics remain attractive with a P/E of 13.12 and P/S of 0.76. Recent news highlights AI server demand growth and new NVIDIA Vera Rubin platform shipments.
SMCI presents a compelling value opportunity with strong AI-driven growth prospects, though investors face risks from competitive pressures and potential regulatory scrutiny. Analyst consensus leans neutral with a $42.33 price target, while institutional interest remains strong given the company's positioning in the expanding AI infrastructure market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →
